An osteogenic sarcoma originally induced in Sprague-Dawley rats by injection of 3zP, has been maintained in this inbred strain of rats by subsequent tumour transfer for over 3 years. During this time isolated intact cells and partially purified membranes have shown a response to both parathyrin (parathyroid hormone) and prostaglandins El and E, with an increase in cyclic A M P and increased adenylate cyclase activity.
The tumour is composed mainly of osteoblast-like cells, which, in common with osteoblasts from bone, are rich in alkaline phosphatase. During tumour growth the activity of serum alkaline phosphatase, after an initial lag, increased and subsequently paralleled the growth rate of the turnour. This rise in serum alkaline phosphatase activity correlated closely with the increase in the size of the tumour ( r = 0.99). In normal rat serum the alkaline phosphatase activity is derived from several isoenzymes, the major sources of which are intestine, liver, kidney and bone. These isoenzymes differ in certain physical properties. Crude preparations of tumour and serum alkaline phosphatase from rats bearing tumours were compared with alkaline phosphatase isoenzymes Fig. 1 . Rapid fall in serum alkaline phosphatase activity after the surgical removal of sarcoma, followed by increased activity of alkaline phosphatase in two rats in which tumours re-occurred The results for four rats are given. In two of them (-) , tumours re-occurred at the original tumour site.
derived from rat intestine, liver and bone. A 15min exposure to 56°C caused a fall in activity of all the alkaline phosphatase isoenzymes, although there was a distinct pattern of heat-stability for each isoenzyme. The intestinal alkaline phosphatase lost 13 % of its initial activity, liver 30% and bone 77% within 15min. Tumour and serum alkaline phosphatases decreased by similar amounts (70% and 77 % respectively); the heatstability of tumour alkaline phosphatase was similar to that of the bone enzyme. The close similarity between the heat-stability of serum and tumour alkaline phosphatase suggests that the tumour is the source of the raised serum alkaline phosphatase activity, and this was confirmed by starch-gel-electrophoretic studies. The electrophoretic mobilities of tumour, serum and normal rat bone alkaline phosphatase were identical, and differed from liver and intestinal alkaline phosphatase.
Surgical removal of the osteogenic sarcoma from rats 17 days after tumour implantation caused a rapid fall in the alkaline phosphatase activity in the serum (half-life 2 h), providing a further indication that the turnour was responsible for the increased serum alkaline phosphatase activity. In two rats in which tumours re-occurred at the original tumour site, the serum alkaline phosphatase activity increased and paralleled tumour growth (Fig. 1) . The high alkaline phosphatase activity found in the serum, together with its rapid degradation demonstrated by the short half-life, indicates a considerable continuous release of enzyme from the tumour in order to maintain this balance. Although this may have suggested that the release of alkaline phosphatase from the tumour is hormonally controlled, particularly in view of the hormone-responsiveness of the sarcoma, extirpation of various endocrine glands did not modify tumour alkaline phosphatase output. Thus castration, ovarirectomy and thyroparathyroidectomy were without effect on serum alkaline phosphatase activity. In thyroparathyroidectomized animals, tumour weights were less than those in intact controls.
Cells from the osteogenic sarcoma have been grown in monolayer culture and have retained their hormone-responsive adenylate cyclase through many subcultures. Cultured cells retained their tumorigenic properties and were very rich in alkaline phosphatase activity. Thus the alkaline phosphatase activity of tumour cells was 3000nmol of substrate cleaved/h per lo5 cells, compared with 80nmol of substrate deaved/h per lo5 cells for rat bone cells (Luben e f al., 1976) . Some 90% of alkaline phosphatase activity was recovered from cultured cells, the remainder from the medium. RNA polymerase (EC 2.7.7.6) from Escherichia cofi is known to possess two binding sites for nucleoside triphosphates (Wu & Goldthwait, 1969) , one of which is presumed to bind the nucleotide that initiates RNA chains, whereas the other binds nucleotides involved in elongating the growing chains. The binding of various mucleotide analogues suggests that at least one of these sites is located on either the B or the 8' subunit (Frischauf & Scheit, 1973; Wu & Wu, 1974; Armstrong et al., 1976) . Periodate oxidizes 1 ,2-diols to the corresponding dicarbonyl compounds, and this reaction has been used to make nucleotide affinity labels for enzymes such aspyruvatecarboxylase(EasterbrookSmith et al., 1976) and galactosyltransferase (Powell & Brew, 1976) . We have used this reaction to synthesize oxidized derivatives of all four ribonucleotides. The oxidized nucleotides all inhibited RNA polymerase under normal assay conditions with a Ki of about 1 mM.
When RNA polymerase was incubated with the nucleotide derivatives together with NaBH4 the extent of inhibition increased with time. The reaction was then quenched with lysine and dialysed to remove unchanged label. A sample was electrophoresed on a 5 % polyacrylamide gel containing sodium dodecyl sulphate. The gel was sliced and the slices were solubilized before being counted for radioactivity in toluene/diphenyloxazole. By comparison with a gel stained for protein with Coomassie Blue it was shown that the radioactivity had co-migrated with the a-subunit of the enzyme. Controls established that (a) failure to quench the reaction with lysine led to all the subunits being labelled, (b) omission of RNA polymerase from the reaction led to total loss of radioactivity during dialysis and (c) a sample of oxidized ATP alone run on the polyacrylamide gel did not give a peak of radioactivity in the same position as the a-band.
We therefore conclude that these nucleotide derivatives are affinity labels which react with the a-subunit. Since all four oxidized nucleotides gave the same result, we tentatively suggest that the elongation site is located on or close to the a-subunit. This is not inconsistent with previous results if it is assumed that this site is located between two subunits. Since the primary sequence of the a-polypeptide is known (Ovchinnikov et al., 1977) , it is possible to characterize the exact lysine residue labelled. 
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